PMOS Tied To Dangerous Heart Hits

A massive new study of more than 2.4 million women finds that those with a common hormone condition face four times the risk of heart disease, even after accounting for weight and blood sugar.

Story Snapshot

  • A Lancet study of over 413,000 women with PMOS, formerly called PCOS, found a fourfold higher heart disease risk compared to women without the condition.
  • The elevated risk stayed even after researchers adjusted for obesity, high blood pressure, high cholesterol, and diabetes.
  • Penn Medicine called it the largest study to date linking PMOS to atherosclerotic cardiovascular disease in the United States.
  • Outside experts note the study only shows a link, not proof, and doesn’t reveal how big the actual danger is for any one woman.

A Massive Dataset Reveals A Troubling Pattern

Researchers pulled health insurance records covering more than 2.4 million American women. Over 413,000 of them had polyendocrine metabolic ovarian syndrome, or PMOS, a condition long known as polycystic ovary syndrome (PCOS). The study, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, tracked these women over time to see who developed heart disease.

The result stood out immediately. Women with PMOS were four times more likely to develop heart disease than women without it. Penn Medicine, whose researchers led the work, described it as the largest study ever done on PMOS and clogged-artery heart disease in the United States.

The Risk Didn’t Disappear After Adjusting For Other Factors

Doctors already know obesity, high blood pressure, high cholesterol, and diabetes raise heart disease risk on their own. Many women with PMOS also deal with these conditions. But when researchers adjusted their numbers to account for all of them, the fourfold risk gap barely moved. That suggests something about PMOS itself, not just the conditions that often come with it, may be driving extra danger to the heart.

Spain’s Science Media Centre noted the finding lines up with what smaller, earlier studies had already suggested about PCOS and cardiovascular trouble. A 2024 review that shaped official PCOS treatment guidelines found women with the condition faced meaningfully higher odds of heart disease and heart attack, though those earlier numbers were smaller than this new fourfold figure.

Why Skeptics Say Slow Down Before Sounding The Alarm

The study cannot prove PMOS causes heart disease. It can only show the two show up together more often than expected. Researchers who reviewed similar PCOS data point out that a “fourfold” risk can sound frightening while still describing a fairly rare event for women in their 30s and 40s, since the disease is uncommon at that age to begin with.

The public summaries of the study don’t share how common heart disease actually was in raw numbers, only the risk ratio between groups. Without that baseline number, it’s hard for an ordinary reader to judge just how worried to be. Experts have flagged this as a common problem when large medical studies condense their most striking finding into a single easy headline.

Data Collection Methods Face Some Scrutiny

The study relied on insurance billing codes, not detailed medical charts, to identify who had PMOS and who developed heart disease. Coding errors happen in large claims databases. Women with PMOS may also see doctors more often, which could mean they get diagnosed with heart problems sooner simply because they’re being watched more closely, not because their true risk is higher.

Researchers also haven’t released the full list of factors they adjusted for, so it’s unclear whether things like smoking, income level, or the severity of a woman’s PMOS symptoms were accounted for. Outside experts and Penn Medicine researchers agree on one clear next step: close monitoring of heart health for women with PMOS, especially given how many are affected nationwide.

A Renamed Condition Adds Confusion To An Old Debate

PMOS is a fairly recent rebranding of the older term PCOS, a shift researchers say better reflects the hormonal and metabolic nature of the disorder. But the name change means some readers searching for information may miss decades of older PCOS research that already flagged heart risks, even if the numbers weren’t always this dramatic.

For millions of American women living with this condition, the takeaway isn’t panic, but attention. Talking to a doctor about heart screening, especially for women managing PMOS alongside weight or blood sugar issues, appears to be the most grounded response medical professionals are recommending right now.

Whether the fourfold number holds up exactly as reported once independent researchers dig into the full data remains to be seen. For now, it stands as the largest signal yet that this common condition deserves more attention from cardiologists, not just gynecologists.

Sources:

youtube.com, pennmedicine.org, medicalxpress.com, pmos.care, madhyamamonline.com, sciencemediacentre.es